Close Menu

More articles about Business News

Cernostics offers an assay that analyzes whole-slide digital images with multiplexed fluorescence to help interpret Barrett's esophagus patient biopsies.

The test is based on 13 genes that form a gene signature in the blood of children with Kawasaki disease, and it enables KD to be distinguished from other diseases.

The company said that since it reported its Q2 2020 financial results, organic testing volumes for its base business have recovered faster than expected.

ArcDia's agreement with Bruker subsidiary Hain Lifescience is exclusive in Germany, Austria, Switzerland, Belgium, the Netherlands, and Luxembourg.

The firm also expects to grant the underwriters a 30-day option to purchase up to an additional $37.5 million worth of shares of its common stock.

Florida's largest county joins several major California counties in deploying Fulgent Genetics' PCR-based COVID-19 tests in a drive-through setting.

Verily's test is a modified version of Thermo Fisher Scientific's authorized TaqPath COVID-19 Combo Kit that can be used with pooled samples.

The company is developing a blood-based test to detect more than 50 cancer types across all stages and identify a tumor's tissue of origin.

The loan will help fund Scope's development of its PCR One point-of-care molecular diagnostic instrument and related respiratory virus panel.

The firm said the financing enables it to progress with the development of an algorithm that would help detect the most common cancers.

The company's stock will now trade on a split-adjusted basis on the Nasdaq after authorization for the split was approved by stockholders.

Healthcare providers need multiplexed tests that can differentiate the flu from the coronavirus so they can treat patients quickly and appropriately.

BillionToOne's test is based on the company's proprietary Sanger sequencing approach, while Sugentech's test detects antibodies against SARS-CoV-2.

The PCR-based test is designed to detect SARS-CoV-2 nucleic acid in a range of specimens including nasal swabs and bronchoalveolar lavage specimens.

Biocartis noted that it has suspended its partnership with Exact Sciences to develop the Idylla IVD Oncotype Dx Breast Recurrence Score test project due to the pandemic.

The firm also announced that all of its coronavirus tests would return additional results for Influenzas A and B by the end of September.

Color Genomics' kit is designed for the unmonitored self-collection of nasal swab specimens for SARS-CoV-2 testing.

Created by BloodPAC members, the resource may serve as a set of generic analytical protocols to help define industry standards for developing liquid biopsy tests.

Google Cloud said that the augmented reality microscope would enable access to artificial intelligence models that can help military doctors with cancer detection.

For the second quarter, sales for its clinical applications jumped nearly 14 percent, while industrial applications fell 7 percent year over year.

Pages